Low-Dose or High-Dose Lenalidomide in Treating Younger Patients With Recurrent, Refractory, or Progressive Pilocytic Astrocytoma or Optic Pathway Glioma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Katherine E Warren
Children's Oncology Group
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
126 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Royal Brisbane and Women'S Hospital
Herston, Queensland, Australia
- Royal Children'S Hospital-Brisbane
Herston, Queensland, Australia
- Queensland Children'S Hospital
South Brisbane, Queensland, Australia
- Royal Children'S Hospital
Parkville, Victoria, Australia
- Princess Margaret Hospital for Children
Perth, Western Australia, Australia
- British Columbia Children'S Hospital
Vancouver, British Columbia, Canada
- Iwk Health Centre
Halifax, Nova Scotia, Canada
- Mcmaster Children'S Hospital at Hamilton Health Sciences
Hamilton, Ontario, Canada
- Kingston Health Sciences Centre
Kingston, Ontario, Canada
- Centre Hospitalier Universitaire Sainte-Justine
Montreal, Quebec, Canada
- the Montreal Children'S Hospital of the Muhc
Montreal, Quebec, Canada
- Starship Children'S Hospital
Grafton, Auckland, New Zealand
- Christchurch Hospital
Christchurch, New Zealand
- Children'S Hospital of Alabama
Birmingham, Alabama, United States
- University of Alabama at Birmingham Cancer Center
Birmingham, Alabama, United States
- Phoenix Childrens Hospital
Phoenix, Arizona, United States
- Arkansas Children'S Hospital
Little Rock, Arkansas, United States
- University of Arkansas for Medical Sciences
Little Rock, Arkansas, United States
- Kaiser Permanente Downey Medical Center
Downey, California, United States
- City of Hope Comprehensive Cancer Center
Duarte, California, United States
- Loma Linda University Medical Center
Loma Linda, California, United States
- Miller Children'S and Women'S Hospital Long Beach
Long Beach, California, United States
- Cedars Sinai Medical Center
Los Angeles, California, United States
- Children'S Hospital Los Angeles
Los Angeles, California, United States
- Valley Children'S Hospital
Madera, California, United States
- Kaiser Permanente-Oakland
Oakland, California, United States
- Children'S Hospital of Orange County
Orange, California, United States
- Lucile Packard Children'S Hospital Stanford University
Palo Alto, California, United States
- Sutter Medical Center Sacramento
Sacramento, California, United States
- University of California Davis Comprehensive Cancer Center
Sacramento, California, United States
- Ucsf Medical Center-Mission Bay
San Francisco, California, United States
- Ucsf Medical Center-Parnassus
San Francisco, California, United States
- Children'S Hospital Colorado
Aurora, Colorado, United States
- Connecticut Children'S Medical Center
Hartford, Connecticut, United States
- Alfred I Dupont Hospital for Children
Wilmington, Delaware, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Golisano Children'S Hospital of Southwest Florida
Fort Myers, Florida, United States
- Lee Memorial Health System
Fort Myers, Florida, United States
- University of Florida Health Science Center - Gainesville
Gainesville, Florida, United States
- Nemours Children'S Clinic-Jacksonville
Jacksonville, Florida, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 5 Jul 2012
- Primary completion
- 30 Jun 2020
- Completion
- 31 Dec 2023
- Last update posted
- 7 Jan 2025
- Registered enrollment
- 75
- Registry id
- NCT01553149
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.